Reaktionsgleichung
[NH2:1][CH:2]1[C:8](=[O:9])[N:7]([CH:10]([CH2:18][CH:19]([CH3:21])[CH3:20])[C:11]([O:13][C:14]([CH3:17])([CH3:16])[CH3:15])=[O:12])[CH2:6][C:5]2[CH:22]=[CH:23][CH:24]=[CH:25][C:4]=2[CH2:3]1.[Br:26][CH:27]([CH2:31][CH2:32][CH2:33][CH2:34][N:35]1[C:39](=[O:40])[C:38]2=[CH:41][CH:42]=[CH:43][CH:44]=[C:37]2[C:36]1=[O:45])[C:28](O)=[O:29].Cl.CN(C)CCCN=C=NCC.O.ON1C2C=CC=CC=2N=N1>ClCCl>[C:14]([O:13][C:11](=[O:12])[CH:10]([N:7]1[C:8](=[O:9])[CH:2]([NH:1][C:28](=[O:29])[CH:27]([Br:26])[CH2:31][CH2:32][CH2:33][CH2:34][N:35]2[C:39](=[O:40])[C:38]3=[CH:41][CH:42]=[CH:43][CH:44]=[C:37]3[C:36]2=[O:45])[CH2:3][C:4]2[CH:25]=[CH:24][CH:23]=[CH:22][C:5]=2[CH2:6]1)[CH2:18][CH:19]([CH3:21])[CH3:20])([CH3:17])([CH3:16])[CH3:15]Komponenten
6
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
Combine 2-(4-amino-3-oxo-1,3,4,5-tetrahydro-benzo[c]azepin-2-yl)-4-methyl-valeric acid, tert-butyl ester (0.34 mmol), 2-bromo-6-phthalimidohexanoic acid (0.189 g, 0.56 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.106 g, 0.55 mmol), and 1-hydroxybenztriazole hydrate ((75 mg, 0.56 mmol) in dicloromethane (8 mL). After 17 hours, evapoarte in vacuo to give a residue, partition the residue between ethyl aceate and an aqueous 5% sulfuric acid solution (about 20 mL). Separate the layers, extract the organic layer with a saturate aqueiosu sodium bicarbonate solution and then brine, dry over Na2SO4, filter, and evaporate in vacuo to give the title compound.
Aufarbeitung
- customevapoarte in vacuo to give a residue
- custompartition the residue between ethyl aceate
- customSeparate the layers
- extractionextract the organic layer with a saturate aqueiosu sodium bicarbonate solution
- dry with materialbrine, dry over Na2SO4
- filtrationfilter
- customevaporate in vacuo
Quellen und Nachweise
- ORD-Eintrag
- ord-62dc9a37de174468a55a0c263a849e4a
- Quelldatensatz
- uspto-grants-2003_04
- Patentnummer
- US06544980B2
Verknüpfte Notizen
Wird geladen…